Nov 10, 2025 06:12AM Exagen (XGN) PT Raised to $15 at BTIG

Nov 4, 2025 08:11AM Exagen Inc. (XGN) Misses Q3 EPS by 15c

Oct 14, 2025 04:59AM Exagen (XGN) PT Raised to $15 at KeyBanc

Sep 11, 2025 03:11AM B.Riley Starts Exagen (XGN) at Buy

Jul 30, 2025 06:58AM Exagen (XGN) PT Raised to $10 at Cantor Fitzgerald

Jul 30, 2025 02:14AM KeyBanc Upgrades Exagen (XGN) to Overweight

Jul 29, 2025 08:41AM Exagen Inc. (XGN) Misses Q2 EPS by 6c

Jul 23, 2025 09:10AM Craig-Hallum Starts Exagen (XGN) at Buy

Jun 23, 2025 09:04AM Exagen Inc (XGN) names Michael Mahler as CSO

Jun 20, 2025 04:24PM Exagen Inc (XGN) Files 1.15M Share Offering by Selling Stockholders

May 15, 2025 07:29AM Exagen (XGN) PT Lowered to $7 at Cantor Fitzgerald

May 8, 2025 08:31AM Exagen Inc (XGN) Prices 3.5M Share Offering at $5.25/sh

May 7, 2025 04:05PM Exagen Inc (XGN) Announces Proposed Public Offering of Common Stock

May 6, 2025 08:25AM KeyBanc Reiterates Sector Weight Rating on Exagen (XGN)

May 5, 2025 04:19PM Exagen Inc. (XGN) Tops Q1 EPS by 2c

Apr 28, 2025 09:01AM Exagen Inc (XGN) Announces Senior Secured Credit Facility with Perceptive Advisors

Mar 17, 2025 07:38AM Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer

Mar 11, 2025 04:40PM Exagen Inc. (XGN) Tops Q4 EPS by 12c

Mar 11, 2025 04:33PM BTIG Reiterates Buy Rating on Exagen (XGN)

Mar 10, 2025 07:18AM Exagen (XGN) PT Lowered to $8 at Cantor Fitzgerald

Nov 14, 2024 04:30PM Exagen Inc (XGN) Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE CTD Platform

Nov 12, 2024 05:00PM Exagen Inc. (XGN) Tops Q3 EPS by 1c

Nov 12, 2024 04:06PM BTIG Reiterates Buy Rating on Exagen (XGN)

Nov 12, 2024 02:12PM KeyBanc Reiterates Sector Weight Rating on Exagen (XGN)

Aug 5, 2024 09:51AM Exagen Inc. (XGN) Tops Q2 EPS by 50c; offers outlook

Aug 1, 2024 09:00AM Exagen Inc (XGN) Appoints Jeffrey G. Black as CFO